A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma

Published:2020-10-07 Issue:2 Volume:88 Page:246-251
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:Neurosurg.

Author:

Peereboom David M,Ye Xiaobu,Mikkelsen Tom,Lesser Glenn J,Lieberman Frank S,Robins H Ian,Ahluwalia Manmeet S,Sloan Andrew E,Grossman Stuart A

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

Link

http://academic.oup.com/neurosurgery/article-pdf/88/2/246/36409451/nyaa412.pdf

Reference24 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

2. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials;Wong;J Clin Oncol,1999

3. Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas;Lamborn;Neuro Oncol,2008

4. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response;Bao;Nature,2006

5. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor;Bao;Cancer Res,2006

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies;Signal Transduction and Targeted Therapy;2024-05-27

2. Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy;Biomolecules;2024-04-15

3. Emerging Therapies for Glioblastoma;Cancers;2024-04-12

4. Novel insights into Notch signaling in tumor immunity: potential targets for cancer immunotherapy;Frontiers in Immunology;2024-02-20

5. TRPM7 transactivates the FOSL1 gene through STAT3 and enhances glioma stemness;Cellular and Molecular Life Sciences;2023-08-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3